<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00128427</url>
  </required_header>
  <id_info>
    <org_study_id>DCASL30501-3</org_study_id>
    <secondary_id>EUDRACT number 2005-001570-28</secondary_id>
    <nct_id>NCT00128427</nct_id>
  </id_info>
  <brief_title>Study of Colchicine to Prevent the Postpericardiotomy Syndrome</brief_title>
  <official_title>Treatment and Prevention of Pericarditis With Colchicine. A Multicenter Double Blind Randomized Trial. The COPPS Trial: COlchicine for the Prevention of Postpericardiotomy Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Azienda Sanitaria Locale 3, Torino</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Azienda Sanitaria Locale 3, Torino</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to determine whether colchicine is safe and effective in the
      prevention of the postpericardiotomy syndrome.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The postpericardiotomy syndrome is a frequent complication after cardiac surgery affecting
      from 20 to 40% of patients. The etiology of this complication is a subject of debate. It is
      commonly believed to be an autoimmune response to pericardial and/or pleural bleeding or
      surgical trauma. Colchicine is safe and effective in the treatment and prevention of
      pericarditis and preliminary data have shown that it may be effective also in the primary
      prevention of the postpericardiotomy syndrome.

      Comparisons: The study will compare the safety and efficacy of colchicine in the primary
      prevention of the postpericardiotomy syndrome in addition to optimal standard care.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2005</start_date>
  <completion_date type="Actual">June 2010</completion_date>
  <primary_completion_date type="Actual">June 2010</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postpericardiotomy syndrome</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Disease-related hospitalization, cardiac tamponade, constrictive pericarditis and relapses</measure>
  </secondary_outcome>
  <enrollment type="Anticipated">360</enrollment>
  <condition>Postpericardiotomy Syndrome</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Colchicine (for 1 month)</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients in the third day after a cardiac surgery operation

          -  Ageâ‰¥ 18 years

          -  Informed consent

        Exclusion Criteria:

        All evaluated before the surgical operation:

          -  Known severe liver disease and/or elevated transaminases &gt;1.5 times the upper limit of
             normality

          -  Serum creatinine &gt;2.5 mg/dl

          -  Serum creatine kinase (CK) over the upper limit of normality or known myopathy

          -  Known gastrointestinal or blood disease

          -  Pregnant or lactating women or women not protected by a contraception method

          -  Known hypersensibility to colchicine

          -  Treatment with colchicine at enrolment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rita TRINCHERO, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Cardiology Department. Maria Vittoria Hospital. ASL 3. Torino.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Massimo IMAZIO, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Cardiology Department. Maria Vittoria Hospital. ASL 3. Torino.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Massimo IMAZIO, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cardiology Department. Maria Vittoria Hospital. ASL 3. Torino.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ospedali Riuniti</name>
      <address>
        <city>Bergamo</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Regionale Bolzano</name>
      <address>
        <city>Bolzano</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Niguarda</name>
      <address>
        <city>Milano</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale di Rivoli</name>
      <address>
        <city>Rivoli</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiology Department. Maria Vittoria Hospital. ASL 3. Torino.</name>
      <address>
        <city>Torino</city>
        <zip>10141</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiac Surgery- Ospedale Mauriziano</name>
      <address>
        <city>Torino</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>June 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 8, 2005</study_first_submitted>
  <study_first_submitted_qc>August 8, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 10, 2005</study_first_posted>
  <last_update_submitted>June 13, 2010</last_update_submitted>
  <last_update_submitted_qc>June 13, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 15, 2010</last_update_posted>
  <responsible_party>
    <name_title>Azienda Sanitaria Locale 3, Torino</name_title>
    <organization>Ospedale Maria Vittoria, Torino</organization>
  </responsible_party>
  <keyword>Postpericardiotomy Syndrome</keyword>
  <keyword>Pericarditis</keyword>
  <keyword>Prevention</keyword>
  <keyword>Colchicine</keyword>
  <keyword>Recurrence</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Pericarditis</mesh_term>
    <mesh_term>Postpericardiotomy Syndrome</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colchicine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

